Cannabis Science Inc (OTCMKTS:CBIS) CFO Robert James Kane sold 1,783,475 shares of the stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $0.02, for a total transaction of $35,669.50. Following the completion of the transaction, the chief financial officer now owns 23,710,717 shares in the company, valued at $474,214.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Robert James Kane also recently made the following trade(s):

  • On Tuesday, September 13th, Robert James Kane sold 2,000,000 shares of Cannabis Science stock. The shares were sold at an average price of $0.01, for a total transaction of $20,000.00.

Cannabis Science Inc (OTCMKTS:CBIS) opened at 0.0248 on Monday. Cannabis Science Inc has a 52 week low of $0.01 and a 52 week high of $0.03. The firm has a 50-day moving average of $0.02 and a 200 day moving average of $0.02. The stock’s market capitalization is $48.79 million.

Insider Buying and Selling by Quarter for Cannabis Science (OTCMKTS:CBIS)

About Cannabis Science

Cannabis Science, Inc is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Receive News & Stock Ratings for Cannabis Science Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabis Science Inc and related stocks with our FREE daily email newsletter.